Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

This study has been completed.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003439

Locations


United States, Pennsylvania
	University of Pittsburgh Cancer Institute
	Pittsburgh, Pennsylvania, United States, 15213

Sponsors and Collaborators

UPMC Cancer Centers

National Cancer Institute (NCI)

Investigators


Study Chair:	Robert P. Edwards, MD	UPMC Cancer Centers